Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-10-25

FDA Approved: ALLERGY RELIEF 24HR — Supplemental Application (VELOCITY PHARMA LLC)

View source ↗

Summary

FDA approved a supplemental application for ALLERGY RELIEF 24HR (levocetirizine dihydrochloride) by Velocity Pharma LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ALLERGY RELIEF 24HR (LEVOCETIRIZINE DIHYDROCHLORIDE)

Snippet

SUPPL AP for ALLERGY RELIEF 24HR (LEVOCETIRIZINE DIHYDROCHLORIDE)